Introduction to the market size, quality and price of generic drugs of Febuxostat

Febuxostat (Febuxostat) is a commonly used drug for the treatment of hyperuricemia and gout, and its demand in the domestic market has continued to grow in recent years. As the patents of original drugs expire, many domestic pharmaceutical companies have launched generic drugs, intensifying market competition and making supply more abundant. The launch of generic drugs not only meets the daily treatment needs of patients, but also provides a more economical choice for medical insurance payment, promoting the expansion of the overall market size.

in the country, generic febuxostat has been launched and included in the medical insurance system. Taking imported drugs as an example, 40mg*14 tablets are priced at more than 100 yuan. Patients can purchase them through hospital pharmacies and enjoy preferential medical insurance reimbursement. Domestic generic drugs are consistent with the original drugs in dosage forms, specifications and usage, and can provide patients with safe and affordable long-term treatment options while reducing treatment costs.

In overseas markets, febuxostat also has two options: original drug and generic drug. The price of Japanese original drug 10mg 100 tablets is about 200 yuan, while the price of Indian generic drug 80mg 30 tablets is about 100 yuan. The drug ingredients are basically the same as the original drug, and the efficacy is reliable. The price of foreign generic drugs is relatively low, which provides economic convenience for some patients. At the same time, the quality and ingredients of the drugs are highly consistent with the original drugs, ensuring the stability of clinical efficacy.

Whether it is domestic generic drugs or drugs purchased overseas, patients should purchase them through formal channels, such as hospital pharmacies or qualified drug suppliers, to ensure drug quality and safety. When choosing generic drugs, you can refer to the drug approval number, manufacturer qualifications and clinical use experience. By standardizing medication and rationally selecting specifications and channels, patients can not only ensure treatment effects, but also reduce their economic burden and achieve safe and sustainable long-term medication management.

Reference materials:https://www.drugs.com/